Photodynamic activities and biodistribution of fluorinated zinc phthalocyanine derivatives in the murine EMT-6 tumour model

International Journal of Cancer

Volumn 72, Issue 2, 1997, Pages 289-294

  Allémann, Eric ^a   Brasseur, Nicole ^b   Kudrevich, Svetlana V ^b   La Madeleine, Carole ^b   Van Lier, Johan E ^b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PHTHALOCYANINE ZINC;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CONTROL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; FEMALE; IRRADIATION; MALE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; PRIORITY JOURNAL; RAT;

EID: 1642443055     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970717)72:2<289::AID-IJC15>3.0.CO;2-B     Document Type: Article

References (19)

1. ALI, H., LANGLOIS, R., WAGNER, J.R., BRASSEUR, N., PAQUETTE, B. and VAN LIER, J.E., Biological activities of phthalocyanines - X. Synthesis and analyses of sulfonated phthalocyanines. Photochem. Photobiol., 47, 713-717 (1988).
2. ALLÉMANN, E., BRASSEUR, N., BENREZZAK, O., ROUSSEAU, J., KUDREVICH, S.V., BOYLE, R.W., LEROUX, J.C., GURNY, R. and VAN LIER, J.E., PEG-coated poly(lactic acid) nanoparticles for the delivery of hexadecafluoro zinc phthalocyanine to EMT-6 mouse mammary tumours. J. Pharm. Pharmacol., 47, 382-387 (1995).
3. ALLÉMANN, E., ROUSSEAU, J., BRASSEUR, N., KUDRLVICH, S.V., LEWIS, K. and VAN LIER, J.E., Photodynamic therapy of tumours with hexadecafluoro zinc phthalocyanine formulated in PEG-coated poly(lactic acid) nanoparticles. Int. J. Cancer, 66, 821-824 (1996).
4. 65Zn as a radiotracer. Brit. J. Cancer, 73, 49-53 (1996).
5. BRASSEUR, N., NGUYEN, T.L., LANGLOIS, R., OUELLET, R., MARENGO, S., HOUDE, D. and VAN LIER, J.E., Synthesis and photodynamic activities of silicon 2,3-naphthalocyanine derivatives. J. med. Chem., 37, 415-420 (1994).
6. CHAN, W.-S., BRASSEUR, N., LA MADELEINE, C. and VAN LIER, J.E., Evidence for different mechanisms of EMT-6 tumour necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin: tumour cell survival and blood flow. Anticancer Res., 16, 1887-1892 (1996).
7. DOUGHERTY, T.J., Yearly review: photodynamic therapy. Photochem. Photobiol., 58, 895-900 (1993).
8. HENDERSON, B.W. and DOUGHERTY, T.J., How does photodynamic therapy work? Photochem. Photobiol., 55, 145-157 (1992).
9. ISELE, U., SCHIEWECK, K., KESSLER, R., VAN HOOGEVEST, P. and CAPRARO, H.G., Pharmacokinetics and body distribution of liposomal zinc phthalocyanine in tumour-bearing mice: influence of aggregation state, panicle size, and composition. J. Pharm. Sci., 84, 166-173 (1995).
10. ISELE, U., VAN HOOGEVEST, P., HILFIKER, R., CAPRARO, H.G., SCHIEWECK, K. and LEUENBERGER, H., Large-scale production of liposomes containing monomeric zinc phthalocyanine by controlled dilution of organic solvents. J. Pharm. Sci., 83, 1608-1616 (1994).
11. KUDREVICH, S., ALI, H.R. and VAN LIER, J.E., Syntheses of monosulfonated phthalocyanines, benzonaphthoporphyrazines and porphyrins via the Meerwein reaction. J. chem. Soc. Perkin Trans. 1, 19, 2767-2774 (1994).
12. MARGARON, P., GRÉGOIRE, M.-J., ŠČASNÁR, V. and VAN LIER, J.E., Structure-photodynamic activity relationships of a series of 4-substituted zinc phthalocyanines. Photochem. Photobiol., 63, 217-223 (1996a).
13. MARGARON, P., MADARNAS, P., OUELLET, R. and VAN LIER, J.E., Biological activities of phthalocyanines. XVII. Histopathologic evidence for different mechanisms of EMT-6 tumour necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or Photofrin. Anticancer Res., 16, 613-620 (1996b).
14. REDDI, E., ZHOU, C., BIOLO, R., MENEGALDO, E. and JORI, G., Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Brit. J. Cancer, 61, 407-411 (1990).
15. ROCKWELL, S.C., KALLMAN, R.F. and FAJARDO, L.F., Characteristics of a serially transplanted mouse mammary tumour and its tissue-culture-adapted derivative. J. nat. Cancer Inst., 49, 735-749 (1972).
16. ROSENTHAL, D.I. and GLATSTEIN, E., Clinical applications of photodynamic therapy. Ann. Med., 26, 405-409 (1994).
17. TADA, H.R., SHIBO, O., KUROSHIMA, K., KOYAMA, M. and TSUKAMOTO, K., An improved colorimetric assay for interleukin 2. J. Immunol. Methods, 93, 157-165 (1986).
18. VAN HILLEGERSBERG, R., KORT, W.J. and WILSON, J.H.R., Current status of photodynamic therapy in oncology. Drugs, 48, 510-527 (1994).
19. VAN LIER, J.E., Phthalocyanines as sensitizers for the photodynamic therapy of cancer. In: D. Kessel (ed.), Photodynamic therapy of cancers, vol. I, pp. 279-291, CRC Press, Boca Raton, FL (1990).